Segment Information - Schedule of Significant Customers (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Product Concentration Risk | Percent of Total Gross Product Revenues | McKesson Corporation
Concentration Risk [Line Items]
Concentration risk percentage	26.00%	26.00%	25.00%
Product Concentration Risk | Percent of Total Gross Product Revenues | Accredo Health Group, Inc.
Concentration Risk [Line Items]
Concentration risk percentage	11.00%	11.00%	12.00%
Product Concentration Risk | Percent of Total Gross Product Revenues | Walgreen Co.
Concentration Risk [Line Items]
Concentration risk percentage	10.00%	10.00%	10.00%
Product Concentration Risk | Percent of Total Gross Product Revenues | Lloyds Pharmacy
Concentration Risk [Line Items]
Concentration risk percentage	10.00%	10.00%	10.00%
Credit Concentration Risk | Percent of Accounts Receivable | McKesson Corporation
Concentration Risk [Line Items]
Concentration risk percentage	17.00%	23.00%
Credit Concentration Risk | Percent of Accounts Receivable | Accredo Health Group, Inc.
Concentration Risk [Line Items]
Concentration risk percentage	10.00%	10.00%
Credit Concentration Risk | Percent of Accounts Receivable | Walgreen Co.
Concentration Risk [Line Items]
Concentration risk percentage	10.00%	10.00%
Credit Concentration Risk | Percent of Accounts Receivable | Lloyds Pharmacy
Concentration Risk [Line Items]
Concentration risk percentage	13.00%	10.00%